Physician profile
Benjamin R Smith
NPI 1922159326
$3,022.50
in general payments reported to CMS, 2019-2025
20 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $81.75 · 2021: $74.67 · 2022: $189 · 2023: $488 · 2024: $1,229 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,851 · Travel and Lodging: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.94 |
| Travel and Lodging | $282.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $843.42 | 2022-2024 | Selectsecure |
| Novartis Pharmaceuticals Corporation | $541.54 | 2019-2025 | |
| Boston Scientific Corporation | $321.57 | 2019-2023 | |
| Pfizer INC. | $216.47 | 2019-2025 | |
| Abbott Laboratories | $171.95 | 2021-2025 | Ensite, Merlin@Home, Accent |
| Amgen INC. | $156.97 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $119.71 | 2022-2025 | Verquvo, Bridion |
| Astrazeneca Pharmaceuticals LP | $111.60 | 2019-2025 | Wainua, Farxiga |
| Janssen Pharmaceuticals, INC | $106.16 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $81.69 | 2019-2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.59 | 2023-2024 | Lifevest |
| Lantheus Medical Imaging, INC. | $56.31 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $50.01 | 2024-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.39 | 2023-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $36.53 | 2020-2022 | |
| Philips North America LLC | $30.78 | 2025 | Event |
| Bridgebio Pharma, INC. | $15.48 | 2025 | Attruby |
| Chiesi USA, INC. | $13.56 | 2020 | |
| Altathera Pharmaceuticals LLC | $8.80 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.